AVTX
Avalo Therapeutics Inc.
$17.83
+$0.09(+0.51%)
71
Overall
80
Value
63
Tech
--
Quality
Market Cap
$281.44M
Volume
164.53K
52W Range
$3.39 - $19.41
Target Price
$35.33
EPS Estimates Overview
| Current Quarter | $-1.56 | Next Quarter | $-1.63 |
| Current Year | $-6.93 | Next Year | $-5.58 |
| QoQ Growth | -4.5% | YoY Growth | +19.5% |
| 3Y EPS CAGR | +91.8% | Target Price | $35.33 |
| Consensus | Buy | Upside | +98.1% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AVTX | $17.83 | +0.5% | 164.53K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |